ePOSTER LISTING

CLICK ON THE ABSTRACT CATEGORIES BELOW TO JUMP TO ITS ACCEPTED ABSTRACTS

EPIDEMIOLOGY OF MS

The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia

Main Author: Seraj Makkawi, Jeddah, Saudi Arabia

Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study

Main Author: Saloua Mrabet, Mannouba, Tunisia

Impact of Gender on Multiple Sclerosis Natural History: Findings from a Tunisian Cohort

Main Author: Saloua Mrabet, Mannouba, Tunisia

Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS

Main Author: Nahid Beladi Moghadam, Tehran, Iran

Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman

Main Author: Salma Al-Abri, Muscat, Oman

Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience

Main Author: Ahmed Essmat, Cairo, Egypt

Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco.

Main Author: Rachid Lotfi, Béni Mellal, Morocco

Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden

Main Author: Meritxell Sabidó Espin, Darmstadt, Germany

Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region

Main Author: Murad Al-Naqshbandi, Dubai, United Arab Emirates

Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia.

Main Author: Awad Al Harbi, Riyadh, Saudi Arabia

A Nationwide Pharmaco Epidemiological Study of Multiple Sclerosis in Greece

Main Author: Christos Bakirtzis, Thessaloniki, Greece

Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province , Iran.

Main Author: Roshanak Mehdipour Dastjerdi, Isfahan, Iran

Familial MS in the South Caspian Sea

Main Author: Seyedmohammad Baghbanian, Sari, Iran

Challenges of MS Patients for Receiving Health Care Services

Main Author: Sharareh Eskandarieh, Tehran, Iran

Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East

Main Author: Samar Farouk Ahmed, Kuwait City, Kuwait

COVID-19 Vaccination in People with Multiple Sclerosis the Kuwait Experience

Main Author: Samar Farouk Ahmed, Kuwait City, Kuwait

Multiple Sclerosis During Pregnancy: Data from the MS Clinic in Benghazi Medical Center

Main Author: Anwaar Mukhtar Bennour, Benghazi, Libya

Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review

Main Author: Hayder K Hassoun, Annajaf Al ashraf, Iraq

Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study

Main Author: Sharareh Eskandarieh, Tehran, Iran

Prevalence of MS in Tehran, Iran in 2020 and Its Forecast for the Next 10 Years

Main Author: Sharareh Eskandarieh, Tehran, Iran

IMMUNOLOGY OF MS

Evaluation of Anti-JVC Antibody Index Evolution in Patients with Multiple Sclerosis

Main Author: Saloua Mrabet, Mannouba, Tunisia

First Study in Iraq About (HLA)-Drb1 * 15:01 as a Genetic Risk Factor for MS Initiation

Main Author: Alaa Hassan Khaliel, Baghdad, Iraq

The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID19 Vaccine

Main Author: Mehran Ghaffari, Tehran, Iran

MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay

Main Author: Alaa Elmazny, Manama, Bahrain

Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study

Main Author: Nahad Sedaghat, Isfahan, Iran

Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients

Main Author: Celia Oreja-Guevara, Madrid, Spain

COVID-19 in Multiple Sclerosis Patients in Dubai: Observational Study

Main Author: Mona Thakre, Dubai, United Arab Emirates

The Role of Gut Microbiata in Multiple Sclerosis

Main Author: Caesar Zahka, Dubai, United Arab Emirates

Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients

Main Author: Ahmed Dahshan, Cairo, Egypt

MRI IN MS

MRI Findings in Late-Onset Multiple Sclerosis; a Systematic Review and Meta-Analysis

Main Author: Amirreza Naseri, Tabriz, Iran

MS DIAGNOSIS

Adrenoleukodystrophy in Adults: About a Case

Main Author: Si Ahmed Hakim, Tizi Ouzou, Algeria

Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis

Main Author: Saloua Mrabet, Mannouba, Tunisia

Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients

Main Author: Celia Oreja-Guevara, Madrid, Spain

Psychotic Symptoms Revealing Multiple Sclerosis: Case Report

Main Author: Sondes Bader, Gabes, Tunisia

A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report

Main Author: Sara Ali Alshamali, Dubai, United Arab Emirates

Radiologically Isolated Syndrome Conversion to Multiple Sclerosis

Main Author: Fatemeh Sabeti, Isfahan, Iran

Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Main Author: Hayder K.Hassoun, Annajaf, Iraq

MS PATHOLOGY

Depression in Multiple Sclerosis

Main Author: Sondes Bader, Gabes, Tunisia

Anxiety in Patients with Multiple Sclerosis

Main Author: Sondes Bader, Gabes, Tunisia

Sleep Disorders in Multiple Sclerosis Patients

Main Author: Sondes Bader, Gabes, Tunisia

Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History

Main Author: Razieh Mofateh, Ahvaz, Iran

Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis

Main Author: Razieh Mofateh, Ahvaz, Iran

Does Multiple Sclerosis Change Lower Limbs Inter-Segmental Coordination During Walking?

Main Author: Razieh Mofateh, Ahvaz, Iran

Association of Multiple Sclerosis and COVID-19 Infection: A Case Report

Main Author: Ismail Ibrahim Ismail, Kuwait city, Kuwait

NEUROMYELITIS OPTICA

Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography

Main Author: Nevin Shalaby, Cairo, Egypt

Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population

Main Author: Kediha Mohamed Islam, Algiers, Algeria

A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder

Main Author: Roshanak Mehdipour, Isfahan, Iran

The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran.

Main Author: Roshanak Mehdipour Dastjerdi, Isfahan, Iran

NMOSD: How Long to Treat

Main Author: Rajarshi Chakraborty, Lucknow, India

PEDIATRIC MS

Lennox-Gastaut Syndrome and MS: Is it a Coincidence?

Main Author: Lilia Megherbi, Tizi Ouzou, Algeria

Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut

Main Author: Georges Saab, Toronto, Canada

RECENT ADVANCES IN MS THERAPY

The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia

Main Author: Seraj Makkawi, Jeddah, Saudi Arabia

Neurofilament Light Chains: A Reliable Biomarker of Disease Activity in MS

Main Author: Ayesha Ashfaq, lahore, Pakistan

Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis

Main Author: Rasha Alderbi, Jeddah, Saudi Arabia

Real-World Experience with Cladribine in the MSBase Registry

Main Author: Helmut Butzkueven, Melbourne, Australia

Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients

Main Author: Asmaa Eissa, Cairo, Egypt

Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets

Main Author: Bassem I Yamout, Beirut, Lebanon

Multiple Sclerosis Specialized Nurses in Saudi Arabia: Challenge, and Opportunities

Main Author: Rola Alarieh, Riyadh, Saudi Arabia

Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS

Main Author: Alessandra Solari, Milan, Italy

Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone

Main Author: Kholoud M. Al-Otaibi, Jeddah, Saudi Arabia

Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab

Main Author: Carrie M. Hersh, Las Vegas, United States

Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis

Main Author: John Foley, Salt Lake City, United States

Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait

Main Author: Raed Alroughani, Kuwait City, Kuwait

Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab

Main Author: Jacqueline Nicholas, Columbus, United States

The Effect of Rituximab on Mood Disorders in Multiple Sclerosis

Main Author: Maryam Poursadeghfard, Shiraz, Iran

Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience)

Main Author: Amr Abdelsalam Zaki, cairo, Egypt

Epidemiology of COVID-19 in Patients with MS: A Hospital-Based Registry

Main Author: Sharareh Eskandarieh, Tehran, Iran

Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab

Main Author: Bassem I. Yamout, Abu Dhabi, United Arab Emirates

Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study

Main Author: Gavin Giovannoni, London, United Kingdom

Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis

Main Author: Roya Abolfazli, Tehran, Iran

Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region

Main Author: Jihad Inshasi, Dubai, United Arab Emirates